SoundCure Engages UC Irvine Scientist to Aid in Development of Tinnitus Technology
07-Jul-2009
Boston, Massachusetts – SoundCure developer of a novel new audio based therapy for the treatment of tinnitus, has hired Dr. Qing Tang as Director of the development efforts to commercialize the technology. Dr. Tang was most recently a postdoctoral student at the University of California at Irvine, where he also received his doctoral degree in Biomedical Engineering. Dr. Tang's research has been in the areas of Intensity Coding in Acoustic and Electric Hearing and Speech Processing for Auditory Prostheses. As Director of Development, Dr. Tang's role will be primarily focused on the development of an automated tool to help in the diagnosis of tinnitus and the generation of our customized tinnitus suppression tones.
About SoundCure and Allied Minds
SoundCure is a privately held startup focused on the commercialization of audio based therapies to treat and suppress tinnitus by leveraging technology first pioneered at UC Irvine. For more informations please visit www.soundcure.com. Allied Minds, Inc. is the premier seed organization for early-stage technology. The company focuses on converting academic discoveries into commercial reality by working exclusively with a network of U.S. universities and national labs. By filling the gap between government grants and traditional venture capitalists, Allied Minds focuses on funding innovations with significant transformative potential. Instead of managing funds, the company fosters early-stage companies through to success, generating value for all stakeholders. Allied Minds has a nationwide footprint with offices in Boston, Seattle, Washington, D.C. and Los Angeles, and a European presence in London, United Kingdom.
About SoundCure and Allied Minds
SoundCure is a privately held startup focused on the commercialization of audio based therapies to treat and suppress tinnitus by leveraging technology first pioneered at UC Irvine. For more informations please visit www.soundcure.com. Allied Minds, Inc. is the premier seed organization for early-stage technology. The company focuses on converting academic discoveries into commercial reality by working exclusively with a network of U.S. universities and national labs. By filling the gap between government grants and traditional venture capitalists, Allied Minds focuses on funding innovations with significant transformative potential. Instead of managing funds, the company fosters early-stage companies through to success, generating value for all stakeholders. Allied Minds has a nationwide footprint with offices in Boston, Seattle, Washington, D.C. and Los Angeles, and a European presence in London, United Kingdom.
